Wei Fan1, Haikou Yang2, Hong Xue3, Yong Sun4, Jun Zhang1. 1. Department of Anesthesiology, Huai'an First People's Hospital, Nanjing Medical University Jiangsu, China. 2. Department of Anesthesiology, Maternal & Child Health Care Hospital of Huai'an Jiangsu, China. 3. Department of Anesthesiology, Huai'an Hospital Affiliated of Xuzhou Medical College and Huai'an Second People's Hospital Jiangsu, China. 4. Department of Burn and Plastic Surgery, Huai'an First People's Hospital, Nanjing Medical University Jiangsu, China.
Abstract
BACKGROUND: To investigated the diagnostic and prognostic value of engulfment and cell motility (ELMO3) in non small cell lung cancer (NSCLC). METHODS: The expression of ELMO3 at mRNA levels were detected using reverse transcription quantitative real-time polymerase chain reaction (qRT-PCR) in 125 NSCLC patients' tissues and adjacent tissues, as well as in the serum of 125 NSCLC patients and 89 healthy controls. Then, receiver operating characteristic curve (ROC), Kaplan-Meier and Cox regression analysis were adopted to estimate the potential diagnostic and prognostic value of ELMO3, respectively. RESULTS: ELMO3 expression level was significantly up-regulated in NSCLC patients' tissues and serum compared with controls (P<0.001). Moreover, the expression of ELMO3 was significantly associated with tumor size (P=0.020), TNM stage (P=0.017), lymph node metastasis (PP=0.045) and distance metastasis (P=0.033). ROC showed the AUC was 0.917, and the optimal cutoff value was 0.735, providing a sensitivity of 92.8% and a specificity of 84.3%. Furthermore, Kaplan-Meier analysis indicated the high expression of ELMO3 could lead to a shorter overall survival time. In multivariate analysis, ELMO3 expression (HR=3.378, 95% CI=1.326-8.587, P=0.011) was proved to be linked with the prognosis of NSCLC and might act as an independent prognostic marker. CONCLUSION: The over-expression of ELMO3 was a potential diagnostic and prognostic marker for NSCLC.
BACKGROUND: To investigated the diagnostic and prognostic value of engulfment and cell motility (ELMO3) in non small cell lung cancer (NSCLC). METHODS: The expression of ELMO3 at mRNA levels were detected using reverse transcription quantitative real-time polymerase chain reaction (qRT-PCR) in 125 NSCLCpatients' tissues and adjacent tissues, as well as in the serum of 125 NSCLCpatients and 89 healthy controls. Then, receiver operating characteristic curve (ROC), Kaplan-Meier and Cox regression analysis were adopted to estimate the potential diagnostic and prognostic value of ELMO3, respectively. RESULTS:ELMO3 expression level was significantly up-regulated in NSCLCpatients' tissues and serum compared with controls (P<0.001). Moreover, the expression of ELMO3 was significantly associated with tumor size (P=0.020), TNM stage (P=0.017), lymph node metastasis (PP=0.045) and distance metastasis (P=0.033). ROC showed the AUC was 0.917, and the optimal cutoff value was 0.735, providing a sensitivity of 92.8% and a specificity of 84.3%. Furthermore, Kaplan-Meier analysis indicated the high expression of ELMO3 could lead to a shorter overall survival time. In multivariate analysis, ELMO3 expression (HR=3.378, 95% CI=1.326-8.587, P=0.011) was proved to be linked with the prognosis of NSCLC and might act as an independent prognostic marker. CONCLUSION: The over-expression of ELMO3 was a potential diagnostic and prognostic marker for NSCLC.
Entities:
Keywords:
ELMO3; Non small cell lung cancer; diagnosis; prognosis
Authors: J L Cabrera-Alarcon; A Carrillo-Vico; J D Santotoribio; A Leon-Justel; R Sanchez-Gil; A Gonzalez-Castro; J M Guerrero Journal: Clin Lab Date: 2011 Impact factor: 1.138
Authors: Michael J Jarzynka; Bo Hu; Kwok-Min Hui; Ifat Bar-Joseph; Weisong Gu; Takanori Hirose; Lisa B Haney; Kodi S Ravichandran; Ryo Nishikawa; Shi-Yuan Cheng Journal: Cancer Res Date: 2007-08-01 Impact factor: 12.701
Authors: Signe Søes; Iben Lyster Daugaard; Brita Singers Sørensen; Andreas Carus; Manuel Mattheisen; Jan Alsner; Jens Overgaard; Henrik Hager; Lise Lotte Hansen; Lasse Sommer Kristensen Journal: Oncoscience Date: 2014-05-23
Authors: Giselly Encinas; Veronica Y Sabelnykova; Eduardo Carneiro de Lyra; Maria Lucia Hirata Katayama; Simone Maistro; Pedro Wilson Mompean de Vasconcellos Valle; Gláucia Fernanda de Lima Pereira; Lívia Munhoz Rodrigues; Pedro Adolpho de Menezes Pacheco Serio; Ana Carolina Ribeiro Chaves de Gouvêa; Felipe Correa Geyer; Ricardo Alves Basso; Fátima Solange Pasini; Maria Del Pilar Esteves Diz; Maria Mitzi Brentani; João Carlos Guedes Sampaio Góes; Roger Chammas; Paul C Boutros; Maria Aparecida Azevedo Koike Folgueira Journal: Oncotarget Date: 2018-04-27
Authors: Mike Boger; Katrin Bennewitz; David Philipp Wohlfart; Ingrid Hausser; Carsten Sticht; Gernot Poschet; Jens Kroll Journal: Front Cell Dev Biol Date: 2022-07-08